Teresa T Kuan from 1322 W Eckerman Ave, West Covina, CA 91790, age 54, Phone: 626 437-0068

Memantine Titration/Compliance Dosage Methods
view source
US Patent:

7810643, Oct 12, 2010
Filed:

Jul 7, 2006
Appl. No.:

11/483039
Inventors:

Bruce A. Firestone - Irvine CA, US
John Jacob Vander Zanden - Edina MN, US
Rodney J. Terwilliger - Buena Park CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Richard Kurjan - Huntington Beach CA, US
Teresa Kuan - Placentia CA, US
Chin-Ming Chang - Tustin CA, US
J. Abraham M. Le Espiritu - Oceanside CA, US
Assignee:

Allergan, Inc. - IRvine CA
International Classification:

B65D 83/04
A61K 9/00
A61K 31/13
US Classification:

206534, 206531, 206532, 206539, 424400, 514662
Abstract:

A titration package and method for enabling compliance with a regimen of changing dosage of medication over a period of time includes a backing having an array of receivers with the array including a plurality of columns and a plurality of rows. A plurality of sets of Memantine tablets are provided with each tablet set having a common dose of medication and a different does than a tablet of a different set. Each set of tablets is disposed in receivers of one having an adjacent row and an adjacent column. Indicia is provided and disposed adjacent to the columns and rows for displaying common days and successive weeks.

Memantine Oral Dosage Forms
view source
US Patent:

20040254251, Dec 16, 2004
Filed:

Jun 15, 2004
Appl. No.:

10/869169
Inventors:

Bruce Firestone - Irvine CA, US
J. Vander Zanden - Dana Point CA, US
Rodney Terwilliger - Dana Point CA, US
Janet Cheetham - Laguna Niguel CA, US
Richard Kurjan - Huntington Beach CA, US
Teresa Kuan - Placentia CA, US
Chin-Ming Chang - Tustin CA, US
J. Abraham Espiritu - Oceanside CA, US
Assignee:

ALLERGAN, INC. - Irvine CA
International Classification:

A61K031/13
US Classification:

514/662000
Abstract:

This invention relates to an oral dosage form containing between 1 mg and 100 mg of memantine, wherein said dosage form does not contain 10 mg of memantine or 20 mg of memantine, and wherein said dosage form is not prepared by the patient or a person administering the drug to the patient who divides the dosage form containing a larger dose of memantine. Other aspects of this invention relate to pharmaceutical products comprising said dosage forms and methods of administering memantine and treating disease with said dosage form.

Memantine Oral Dosage Forms
view source
US Patent:

20060251717, Nov 9, 2006
Filed:

Jul 13, 2006
Appl. No.:

11/457182
Inventors:

Bruce Firestone - Irvine CA, US
J. Vander Zanden - Dana Point CA, US
Rodney Terwilliger - Buena Park CA, US
Janet Cheetham - Laguna Niguel CA, US
Richard Kurjan - Huntington Beach CA, US
Teresa Kuan - Placentia CA, US
Chin-Ming Chang - Tustin CA, US
J. Abraham Espiritu - Oceanside CA, US
International Classification:

A61K 31/717
A61K 31/13
A61K 9/20
US Classification:

424464000, 514057000, 514663000
Abstract:

This invention relates to an oral dosage form containing between 1 mg and 100 mg of memantine, wherein said dosage form does not contain 10 mg of memantine or 20 mg of memantine, and wherein said dosage form is not prepared by the patient or a person administering the drug to the patient who divides the dosage form containing a larger dose of memantine. Other aspects of this invention relate to pharmaceutical products comprising said dosage forms and methods of administering memantine and treating disease with said dosage form.

Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
view source
US Patent:

20130197051, Aug 1, 2013
Filed:

Mar 13, 2013
Appl. No.:

13/802076
Inventors:

Allergan Sales, LLC - Irvine CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Teresa H. Kuan - Placentia CA, US
David F. Power - Trabuco Canyon CA, US
Assignee:

ALLERGAN SALES, LLC - Irvine CA
International Classification:

A61K 31/407
US Classification:

514413
Abstract:

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain
view source
US Patent:

20130203833, Aug 8, 2013
Filed:

Mar 14, 2013
Appl. No.:

13/830080
Inventors:

Allergan Sales, LLC - Irvine CA, US
Janet K. Cheetham - Laguna Niguel CA, US
Teresa H. Kuan - Placentia CA, US
David F. Power - Trabuco Canyon CA, US
Assignee:

ALLERGAN SALES, LLC - Irvine CA
International Classification:

A61K 31/407
US Classification:

514413
Abstract:

Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.

Poly(Benzalkonium Salt) As An Anti-Microbial Agent For Aqueous Drug Compositions
view source
US Patent:

56837097, Nov 4, 1997
Filed:

May 5, 1994
Appl. No.:

8/238560
Inventors:

Akira Yamada - Claremont CA
Teresa H. Kuan - Placentia CA
Ajay Vasudev Pandurangi - Alta Loma CA
Assignee:

CIBA Vision Corporation - Duluth GA
International Classification:

A01N 2510
US Classification:

424409
Abstract:

A package containing an aqueous drug composition containing an insoluble resin comprising benzalkonium salt units in an amount sufficient to inhibit growth of microbes in said aqueous drug solution. Typically, the insoluble resin is a polymer having repeating units of the formula: --�CH. sub. 2 --CH(Ar)!-- wherein Ar=a group of the formula: -Phe-CH. sub. 2 --N. sup. + (CH. sub. 3). sub. 2 R X. sup. - wherein R=long chain alkyl such as C. sub. 8-18 alkyl, Phe=phenylene, and X. sup. - is a pharmaceutically acceptable counter anion such as Cl. sup. -.